logo

For the Inventor, By the Inventor

Daegu, South Korea

Hong Gil Nam

This inventor holds 6 USPTO granted patents. Top assignees: Institute for Basic Science, Daegu Gyeongbuk Institute of Science and Technology, Pohang University of Science and Technology Foundation. Active years: 2011-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hong Gil Nam. Retrieved from https://idiyas.com/inventor/hong-gil-nam

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 6

% Patents Active = 83.3

Average Co-Inventor Count = 3.7

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Gyeongsangbuk-do, KR (2011)
  • Seoul, KR (2021)
  • Daegu, KR (2017 - 2022)

Company Filing History:

goldMedal4 out of 99 
 
Institute for Basic Science
 patents
silverMedal3 out of 281 
 
Daegu Gyeongbuk Institute of Science and Technology
 patents
bronzeMedal3 out of 1,123 
 
Pohang University of Science and Technology Foundation
 patents
4. 1 out of 1 
 
Anlbio
 patent
5. 1 out of 1 
 
Daegu Gyeongbuk Institute of Science
 patent
6. 1 out of 207 
 
Ewha University-Industry Collaboration Foundation
 patents
where one patent can have more than one assignee

Years Active: 2011-2025

Loading Chart...
6 patents (USPTO):Explore Patents
1. 12359255 - Method for determining decrease in functions of hippocampus by using correlation between micro RNA and NMDA receptor, method for inhibiting decrease in functions, and method for screening for inhibitors of decrease in functions (2025-07-15),
2. 11359245 - Method for determining decrease in functions of hippocampus by using correlation between micro RNA and NMDA receptor, method for inhibiting decrease in functions, and method for screening for inhibitors of decrease in functions (2022-06-14),
3. 11013221 - Anti-aging transgenic Caenorhabditis elegans (2021-05-25),
4. 10704099 - Method for determining decrease in functions of hippocampus by using correlation between micro RNA and NMDA receptor, method for inhibiting decrease in functions, and method for screening for inhibitors of decrease in functions (2020-07-07),
5. 9681648 - Method for manufacturing transgenic caenorhabditis elegans with DNA methyltransferase and use thereof (2017-06-20),
6. 7897836 - Method for changing seed productivity of plant by controlling the level of AtSPF3 in plant (2011-03-01),

Title: The Innovative Journey of Inventor Hong Gil Nam

Introduction: Hong Gil Nam, a pioneering inventor hailing from Daegu, South Korea, has made significant contributions to the field of technology through his groundbreaking innovations.

Latest Patents: Hong Gil Nam's latest patents include advancements in artificial intelligence algorithms for autonomous vehicles, smart home technology for energy efficiency, and wearable health monitoring devices.

Career Highlights: With a career spanning over two decades, Hong Gil Nam has established himself as a leading figure in the tech industry. He has worked with top research institutions and tech companies to bring his inventions to life, revolutionizing various sectors along the way.

Collaborations: Throughout his career, Hong Gil Nam has collaborated with renowned engineers, designers, and scientists to push the boundaries of technological innovation. His partnerships with leading universities and tech giants have led to the development of cutting-edge products that have transformed the way we live and work.

Conclusion: In conclusion, Hong Gil Nam's relentless pursuit of innovation and his passion for creating technology that enhances our daily lives have solidified his reputation as a visionary inventor. His contributions to the tech industry continue to inspire future generations of inventors and pave the way for a more connected and efficient world.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…